Message-ID: <20542650.1075840215342.JavaMail.evans@thyme>
Date: Thu, 12 Oct 2000 02:10:00 -0700 (PDT)
From: brown_mary_jo@lilly.com
To: alfred.gilman@email.swmed.edu, george.fisher@kodak.com, 
	jterzuoli@ibjwhitehall.com, karen.n.horn@marsh.com, 
	kenneth.lay@enron.com, kseifert@kcc.com, prendergast@mayo.edu, 
	scb@purdue.edu, win.bischoff@ssmb.com
Subject: **PRESS RELEASE**SLIL Biomedical Announces Deal with Elanco Animal
 Health
Cc: brown_mary_jo@lilly.com
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
Bcc: brown_mary_jo@lilly.com
X-From: BROWN_MARY_JO@LILLY.COM
X-To: alfred.gilman@email.swmed.edu, george.fisher@kodak.com, jterzuoli@ibjwhitehall.com, karen.n.horn@marsh.com, kenneth.lay@enron.com, kseifert@kcc.com, prendergast@mayo.edu, scb@purdue.edu, win.bischoff@ssmb.com
X-cc: BROWN_MARY_JO@LILLY.COM
X-bcc: 
X-Folder: \Kenneth_Lay_Dec2000\Notes Folders\All documents
X-Origin: LAY-K
X-FileName: klay.nsf

This press release was issued yesterday by SLIL Biomedical Corp.

(See attached file: SLIL-Elanco Agreement.doc)


COLLEEN PARKER
Corporate Communications
276-3402



 - SLIL-Elanco Agreement.doc